Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000814133-25-000017
Filing Date
2025-02-11
Accepted
2025-02-11 17:37:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4763
  Complete submission text file 0000814133-25-000017.txt   6536
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS LP (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Subject) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87928 | Film No.: 25611049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)